Search Results - "Polizzi, Donatella"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    BBR 3464: A Novel Triplatinum Complex, Exhibiting a Preclinical Profile of Antitumor Efficacy Different from Cisplatin by MANZOTTI, C, PRATESI, G, PEZZONI, G, ZUNINO, F, MENTA, E, DI DOMENICO, R, CAVALLETTI, E, FIEBIG, H. H, KELLAND, L. R, FARRELL, N, POLIZZI, D, SUPINO, R

    Published in Clinical cancer research (01-07-2000)
    “…Multinuclear platinum complexes represent a new class of anticancer agents, distinct in terms of DNA binding features and the profile of antitumor activity…”
    Get full text
    Journal Article
  2. 2

    Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines by Perego, P, Corna, E, De Cesare, M, Gatti, L, Polizzi, D, Pratesi, G, Supino, R, Zunino, F

    Published in Current medicinal chemistry (01-01-2001)
    “…Cellular resistance to anthracyclines is a major limitation of their clinical use in the treatment of human tumors. Resistance to doxorubicin is described as a…”
    Get more information
    Journal Article
  3. 3

    Oral Efficacy and Bioavailability of a Novel Taxane by Polizzi, D, Pratesi, G, Monestiroli, S, Tortoreto, M, Zunino, F, Bombardelli, E, Riva, A, Morazzoni, P, Colombo, T, D'Incalci, M, Zucchetti, M

    Published in Clinical cancer research (01-05-2000)
    “…A novel taxane (IDN 5109), originally selected for its ability to overcome P-glycoprotein-mediated drug resistance, is characterized by an improved preclinical…”
    Get full text
    Journal Article
  4. 4

    Molecular mechanisms of resistance to taxanes and therapeutic implications by Zunino, Franco, Cassinelli, Giuliana, Polizzi, Donatella, Perego, Paola

    Published in Drug resistance updates (01-12-1999)
    “…The mechanism of resistance to taxanes has not been fully elucidated. Since Taxol is a substrate for P-glycoprotein, overexpression of this transport system is…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts by Supino, R, Polizzi, D, Pavesi, R, Pratesi, G, Guano, F, Capranico, G, Palumbo, M, Sissi, C, Richter, S, Beggiolin, G, Menta, E, Pezzoni, G, Spinelli, S, Torriani, D, Carenini, N, Dal Bo, L, Facchinetti, F, Tortoreto, M, Zunino, F

    Published in Oncology (01-01-2001)
    “…Systematic investigation of a novel series of intercalating agents, 9-aza-anthrapyrazoles, has led to the identification of a promising analogue, BBR 3438…”
    Get more information
    Journal Article
  7. 7

    Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic by Dantzig, A H, Law, K L, Cao, J, Starling, J J

    Published in Current medicinal chemistry (01-01-2001)
    “…Multidrug resistance may be conferred by P-glycoprotein (Pgp, ABCB1) or the multidrug resistance associated protein (MRP). These membrane proteins are members…”
    Get more information
    Journal Article
  8. 8

    A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes by Cassinelli, Giuliana, Supino, Rosanna, Perego, Paola, Polizzi, Donatella, Lanzi, Cinzia, Pratesi, Graziella, Zunino, Franco

    Published in International journal of cancer (01-06-2001)
    “…Loss of p53 function has been linked to increased responsiveness to taxane treatment of ovarian carcinoma in clinical studies. We recently reported that the…”
    Get full text
    Journal Article
  9. 9

    A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts by POLIZZI, D, PRATESI, G, TORTORETO, M, SUPINO, R, RIVA, A, BOMBARDELLI, E, ZUNINO, F

    Published in Cancer research (Chicago, Ill.) (01-03-1999)
    “…Clinically available taxanes represent one of the most promising class of antitumor agents, despite several problems with their solubility and toxicity. In an…”
    Get full text
    Journal Article
  10. 10

    Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin by Cassinelli, Giuliana, Lanzi, Cinzia, Pensa, Tiziana, Gambetta, Romolo A, Nasini, Gianluca, Cuccuru, Giuditta, Cassinis, Marco, Pratesi, Graziella, Polizzi, Donatella, Tortoreto, Monica, Zunino, Franco

    Published in Biochemical pharmacology (15-06-2000)
    “…Targeting of deregulated protein tyrosine kinases has been proposed as a new approach in the therapeutic intervention against pathological processes including…”
    Get full text
    Journal Article
  11. 11

    Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145 prostate cancer cells by Moretti, Roberta M., Marelli, Marina Montagnani, Motta, Marcella, Polizzi, Donatella, Monestiroli, Silvia, Pratesi, Graziella, Limonta, Patrizia

    Published in The Prostate (01-03-2001)
    “…BACKGROUND RORα is a transcription factor which belongs to the family of orphan nuclear receptors. The regulatory functions of this receptor are still poorly…”
    Get full text
    Journal Article
  12. 12

    Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs by Pratesi, Graziella, Polizzi, Donatella, Perego, Paola, Dal Bo, Laura, Zunino, Franco

    Published in Biochemical pharmacology (01-07-2000)
    “…A variety of cytotoxic agents effective as antitumor drugs are known to kill tumor cells through induction of apoptosis as the most relevant modality of cell…”
    Get full text
    Journal Article
  13. 13

    Doxorubicin disaccharide analogue : Apoptosis-related improvement of efficacy in vivo by ARCAMONE, F, ANIMATI, F, LOMBARDI, P, MADAMI, A, MANZINI, S, MONTEAGUDO, E, POLIZZI, D, PRATESI, G, RIGHETTI, S. C, SALVATORE, C, SUPINO, R, ZUNINO, F, BERETTONI, M, BIGIONI, M, CAPRANICO, G, CASAZZA, A. M, CASERINI, C, CIPOLLONE, A, DE CESARE, M, FRANCIOTTI, M

    “…Although doxorubicin remains one of the most effective agents for the treatment of solid tumors, there is an intensive effort to synthesize doxorubicin…”
    Get full text
    Journal Article
  14. 14

    Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts by PRATESI, G, DE CESARE, M, SALVATORE, C, CASAZZA, A, ARCAMONE, F, ZUNINO, F, CASERINI, C, PEREGO, P, DAL BO, L, POLIZZI, D, SUPINO, R, BIGIONI, M, MANZINI, S, IAFRATE, E

    Published in Clinical cancer research (01-11-1998)
    “…On the basis of a structure-activity study of a new series of anthracycline disaccharides, we recently identified a doxorubicin analogue (MEN 10755) with a…”
    Get full text
    Journal Article
  15. 15
  16. 16